ANALISIS KINERJA KEUANGAN BERBASIS RASIO PADA PERUSAHAAN MANUFAKTUR SUB-SEKTOR FARMASI YANG TERDAFTAR PADA BURSA EFEK INDONESIA PERIODE TAHUN 2012-2016

Authors

  • Siti Aisyah Mahasiswa Prodi Akuntansi STIE-IBEK Pangkalpinang
  • Fery Panjaitan Dosen Prodi Akuntansi STIE-IBEK Pangkalpinang
  • Arka'a Ahmad Agin Dosen Prodi Manajemen STIE-IBEK Pangkalpinang

Keywords:

Pharmaceutical Sub-sector, Liquidity Ratio, Solvency Ratio, Profitability Ratio, Activity Ratio

Abstract

         Each company in carrying out its activities requires information about the condition of the company that occurs from year to year. One way to find out whether the company is carrying out its activities is by measuring financial performance. The pharmaceutical industry is a type of company that in its activities produce medicinal products for health. The pharmaceutical industry has considerable competition in maximizing company performance. The purpose of this study is to determine the financial performance of pharmaceutical sub-sector manufacturing companies listed on the Indonesia Stock Exchange measured from liquidity (Current ratio and cash ratio), solvency (debt to equity ratio and debt to assets ratio), profitability (return on equity and return on asset), and activity (inventory turn over and total asset turn over). Based on observations Viewed from the current ratio of financial performance of companies, especially Darya Varia Laboratoria Tbk company included in good criteria in the year 2012-2014 but decreased until in 2015-2016. While the review of the company's cash ratio, especially in Pyridam Farma Tbk company declared illiquid. Judged from the Debt to equity ratio, the company's financial performance, especially in the SCPI company, can not guarantee its debt and is considered bad. Meanwhile, when viewed from the Debt to asset ratio of the company SCPI is included in the good criteria both in carrying out its obligations. Judged from the Return on equity, the company's financial performance is said to be good. While when viewed from the Return on Assets that the company especially on INAF company said to be profitable. Judging from the inventory turn over the financial performance of the company, especially in the company SCPI showed a rotation that is not good and ran slowly. While in terms of total asset turnover of all companies from eight observed companies is said to be less good because of the decrease in total asset turnover in each year.

Author Biographies

Fery Panjaitan, Dosen Prodi Akuntansi STIE-IBEK Pangkalpinang

Dosen Pembimbing I

Arka'a Ahmad Agin, Dosen Prodi Manajemen STIE-IBEK Pangkalpinang

Dosen Pembimbing II

Published

2018-11-01

How to Cite

Aisyah, S., Panjaitan, F., & Ahmad Agin, A. (2018). ANALISIS KINERJA KEUANGAN BERBASIS RASIO PADA PERUSAHAAN MANUFAKTUR SUB-SEKTOR FARMASI YANG TERDAFTAR PADA BURSA EFEK INDONESIA PERIODE TAHUN 2012-2016. Jurnal Akuntansi Bisnis Dan Keuangan, 5(2), 141–149. Retrieved from https://e-jurnal.stie-ibek.ac.id/index.php/JABK/article/view/268

Most read articles by the same author(s)

<< < 1 2 3 4 5 6